Attention Bias Modification Treatment for Warzone-Related Posttraumatic Stress Disorder (PTSD)
- Conditions
- Posttraumatic Stress Disorder
- Registration Number
- NCT01564667
- Lead Sponsor
- Creighton University
- Brief Summary
Veterans with Posttraumatic Stress Disorder (PTSD) will be randomly assigned to either Attention Bias Modification Treatment (ABMT) designed to reduce bias toward threat or a placebo control condition not designed to change attention patterns. Outcome measures will be PTSD, anxiety, depression, and alexithymia symptoms as measured by standard psychological interviews and questionnaires. Participants will also be invited to participate in physiological testing before and after receiving AMBT or placebo to serve as additional outcome measures and assess brain functioning, heart rate, and muscle tension.
The investigators expect to see significant PTSD symptom reduction in the Attention Bias Modification Treatment (ABMT) group relative to the placebo control group in which no symptomatic relief is expected. At the end of the study, if ABMT is shown to be effective, we will offer active ABMT to those participants randomly assigned to the placebo arm if they would like to receive the treatment.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 51
- Veterans with Posttraumatic Stress Disorder (PTSD) serving in United States Military after March 20, 2003.
- Schizophrenia
- Bipolar Disorder
- Obsessive Compulsive Disorder
- Head Injury with Loss of Consciousness for more than 30 minutes
- Active Alcohol/Substance Dependence in past 6 months
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Will Posttraumatic Stress Disorder and Symptom decrease with intervention 8 weeks Using Clinician-Administered PTSD Scale (CAPS): The clinician-Administered PTSD Scale (CAPS) is a 30-item structured interview that corresponds to the DSM-IV criteria for PTSD (Blake, Weathers, Nagy, Kaloupek, Charney, \& Keane, 1995) to assess symptoms of PTSD outcome.
- Secondary Outcome Measures
Name Time Method Other psychiatics symptoms (ie Depression, Anger, Anxiety) 8 weeks To assess potential decrease in psychiatric symptoms associated with PTSD, by comparing pre intervention and post intervention scores on psychological measures of deprssion, anger and anxiety.
Trial Locations
- Locations (1)
Creighton University
🇺🇸Omaha, Nebraska, United States
Creighton University🇺🇸Omaha, Nebraska, United States